{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:41:22Z","timestamp":1787067682548,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["1.1.1.2\/VIAA\/3\/19\/398"],"award-info":[{"award-number":["1.1.1.2\/VIAA\/3\/19\/398"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bioorg.2023.106725","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T11:00:51Z","timestamp":1688814051000},"page":"106725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["4-Cyanamido-substituted benzenesulfonamides act as dual carbonic anhydrase and cathepsin inhibitors"],"prefix":"10.1016","volume":"139","author":[{"given":"Morteza","family":"Abdoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa","family":"Krasniqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"G\u00fctschow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raivis","family":"\u017dalubovskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.106725_b0005","first-page":"2","article-title":"Assessment of Pain: Types, Mechanism and Treatment","volume":"1","author":"\u015awieboda","year":"2013","journal-title":"Pain."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106725_b0010","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jpainsymman.2009.05.003","article-title":"Pharmacological Management of Neuropathic Pain in Older Adults: An Update on Peripherally and Centrally Acting Agents","volume":"38","author":"McGeeney","year":"2009","journal-title":"J. Pain Symptom Manag."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106725_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(98)00048-3","article-title":"The Induction of Pain: An Integrative Review","volume":"57","author":"Millan","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bioorg.2023.106725_b0020","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic Pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.bioorg.2023.106725_h0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3959(94)90045-0","article-title":"Non-steroidal Anti-inflammatory Drugs and Spinal Nociceptive Processing","volume":"59","author":"McCormack","year":"1994","journal-title":"Pain."},{"key":"10.1016\/j.bioorg.2023.106725_h0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40122-017-0091-4","article-title":"Pharmacotherapy for Neuropathic Pain: A Review","volume":"6","author":"Fornasari","year":"2017","journal-title":"Pain Ther."},{"key":"10.1016\/j.bioorg.2023.106725_h0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bmcl.2018.11.048","article-title":"Discovery and Evaluation of Novel FAAH inhibitors in Neuropathic Pain Model","volume":"29","author":"Bhuniya","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106725_b0030","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2165\/11596280-000000000-00000","article-title":"Combination Therapy for Neuropathic Pain: A Review of Current Evidence","volume":"25","author":"Vorobeychik","year":"2011","journal-title":"CNS Drugs."},{"key":"10.1016\/j.bioorg.2023.106725_b0035","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/WCO.0000000000000980","article-title":"Advances in the Treatment of Neuropathic Pain","volume":"34","author":"Attal","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bioorg.2023.106725_b0040","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/14737175.2016.1193009","article-title":"Carbonic Anhydrase Inhibition and the Management of Neuropathic Pain","volume":"16","author":"Supuran","year":"2016","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bioorg.2023.106725_h0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2006.11.017","article-title":"Role of the Cysteine Protease Cathepsin S in Neuropathic Hyperalgesia","volume":"130","author":"Barclay","year":"2007","journal-title":"Pain."},{"key":"10.1016\/j.bioorg.2023.106725_h0060","doi-asserted-by":"crossref","first-page":"10655","DOI":"10.1073\/pnas.0610811104","article-title":"Inhibition of Spinal Microglial Cathepsin S for the Reversal of Neuropathic Pain","volume":"104","author":"Clark","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2023.106725_h0065","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1021\/jm800839j","article-title":"Discovery of Orally Bioavailable Cathepsin S Inhibitors for the Reversal of Neuropathic Pain","volume":"51","author":"Irie","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106725_h0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2202-9-80","article-title":"Differential Expression of Cathepsin S and X in the Spinal Cord of a Rat Neuropathic Pain Model","volume":"9","author":"Leichsenring","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.bioorg.2023.106725_h0075","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2174\/156802610791113432","article-title":"Recent Advances in the Design of Cathepsin S Inhibitors","volume":"10","author":"Wiener","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106725_h0080","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1517\/13543776.2011.550574","article-title":"Cathepsin S Inhibitors: WO2010070615","volume":"21","author":"L\u00f6ser","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2023.106725_h0085","article-title":"Cathepsin S as a Potential Therapeutic Target for Chronic Pain","volume":"7","author":"Montague-Cardoso","year":"2020","journal-title":"Med. Drug Discov."},{"key":"10.1016\/j.bioorg.2023.106725_b0050","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH Regulation in Tumours as a Therapeutic Strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2023.106725_b0055","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/med.21713","article-title":"Progress in the Development of Human Carbonic Anhydrase Inhibitors and their Pharmacological Applications: Where are we today?","volume":"40","author":"Mishra","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2023.106725_b0060","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.bmcl.2011.12.134","article-title":"Carbonic Anhydrase VII is S-glutathionylated without Loss of Catalytic Activity and Affinity for Sulfonamide Inhibitors","volume":"22","author":"Truppo","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106725_b0065","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1016\/j.bmc.2007.04.020","article-title":"Carbonic Anhydrases as Targets for Medicinal Chemistry","volume":"15","author":"Supuran","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106725_b0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic Anhydrases: Novel Therapeutic Applications for Inhibitors and Activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2023.106725_b0075","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpain.2014.01.001","article-title":"Inhibition of Carbonic Anhydrase Augments GABAA Receptor-mediated Analgesia via a Spinal Mechanism of Action","volume":"15","author":"Asiedu","year":"2014","journal-title":"J. Pain."},{"key":"10.1016\/j.bioorg.2023.106725_b0080","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.pain.2009.11.015","article-title":"Acetazolamide and Midazolam Act Synergistically to Inhibit Neuropathic Pain","volume":"148","author":"Asiedu","year":"2010","journal-title":"Pain."},{"key":"10.1016\/j.bioorg.2023.106725_h0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1107\/S0907444902021479","article-title":"Lysosomal Cysteine Proteases (Cathepsins): Promising Drug Targets","volume":"59","author":"Turk","year":"2003","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bioorg.2023.106725_h0130","first-page":"91","article-title":"Cathepsins Mediate Tumor Metastasis, World","volume":"4","author":"Tan","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2023.106725_h0135","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fcell.2017.00114","article-title":"The Multifaceted Role of the Lysosomal Protease Cathepsins in Kidney Disease","volume":"5","author":"Cocchiaro","year":"2017","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.bioorg.2023.106725_h0140","doi-asserted-by":"crossref","first-page":"10497","DOI":"10.1021\/acs.jmedchem.9b00683","article-title":"Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity?","volume":"62","author":"Cianni","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106725_h0145","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.3390\/ijms23169089","article-title":"The Key Role of Lysosomal Protease Cathepsins in Viral Infections","volume":"23","author":"Scarcella","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0090.1","doi-asserted-by":"crossref","unstructured":"(a) S. Patyar, A. Prakash, B. Medhi, Dual Inhibition: a Novel Promising Pharmacological Approach for Different Disease Conditions, J. Pharm. Pharmacol. 63 (2011) 459-471. (b) R. Roy, T. Ria, D. RoyMahaPatra, U.H. Sk, Single Inhibitors versus Dual Inhibitors: Role of HDAC in Cancer, ACS Omega. 8 (2023) 16532-16544","DOI":"10.1021\/acsomega.3c00222"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0090.2","doi-asserted-by":"crossref","unstructured":"(c) N.M. Raghavendra, D. Pingili, S. Kadasi, A. Mettu, S.V. Prasad, Dual or multi-targeting inhibitors: The next generation anticancer agents, Eur. J. Med. Chem. 143 (2018) 1277-1300.","DOI":"10.1016\/j.ejmech.2017.10.021"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0095.1","doi-asserted-by":"crossref","unstructured":"(a) C.T. Supuran, Structure-based Drug Discovery of Carbonic Anhydrase Inhibitors, J. Enzyme Inhib. Med. Chem. 27 (2012) 759-772","DOI":"10.3109\/14756366.2012.672983"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0095.2","doi-asserted-by":"crossref","unstructured":"(b) F. Carta, C.T. Supuran, A. Scozzafava, Sulfonamides and Their Isosters as Carbonic Anhydrase Inhibitors, Future Med. Chem. 6 (2014) 1149-1165","DOI":"10.4155\/fmc.14.68"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0095.3","doi-asserted-by":"crossref","unstructured":"(c) S. K\u00f6hler, S. Ouahrani-Bettache, J.Y. Winum, Brucella suis Carbonic Anhydrases and Their Inhibitors: Towards Alternative Antibiotics? J. Enzyme Inhib. Med. Chem. 32 (2017) 683-687","DOI":"10.1080\/14756366.2017.1295451"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0095.4","doi-asserted-by":"crossref","unstructured":"(d) K. Demir-Yaz\u0131c\u0131, S. Bua, N.M. Akg\u00fcne\u015f, A. Akdemir, C.T. Supuran, \u00d6. G\u00fczel-Akdemir, Indole-Based Hydrazones Containing A Sulfonamide Moiety as Selective Inhibitors of Tumor-Associated Human Carbonic Anhydrase Isoforms IX and XII, Int. J. Mol. Sci. 20 (2019) 2354.","DOI":"10.3390\/ijms20092354"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0100.1","doi-asserted-by":"crossref","unstructured":"(a) M. Frizler, M. Stirnberg, MT. Sisay, M. G\u00fctschow, Development of Nitrile-based Peptidic Inhibitors of Cysteine Cathepsins, Curr. Top. Med. Chem. 10 (2010) 294-322","DOI":"10.2174\/156802610790725452"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0100.2","doi-asserted-by":"crossref","unstructured":"(b) F.F. Fleming, L. Yao, P.C. Ravikumar, L. Funk, B.C. Shook, Nitrile-containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore, J. Med. Chem. 53 (2010) 7902-7917","DOI":"10.1021\/jm100762r"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0100.3","doi-asserted-by":"crossref","unstructured":"(c) A. Lee-Dutra, D.K. Wiener, S. Sun, Cathepsin S Inhibitors: 2004-2010, Expert Opin. Ther. Pat. 21 (2011) 311-337","DOI":"10.1517\/13543776.2011.553800"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0100.4","doi-asserted-by":"crossref","unstructured":"(d) S. Brogi, R. Ibba, S. Rossi, S. Butini, V. Calderone, S. Gemma, G. Campiani, Covalent Reversible Inhibitors of Cysteine Proteases Containing the Nitrile Warhead: Recent Advancement in the Field of Viral and Parasitic Diseases, Molecules. 27 (2022) 2561.","DOI":"10.3390\/molecules27082561"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0105.1","doi-asserted-by":"crossref","unstructured":"For examples, see (a) J.P. Falgueyret, R.M. Oballa, O. Okamoto, G. Wesolowski, Y. Aubin, R.M. Rydzewski, P. Prasit, D. Riendeau, S.B. Rodan, M.D. Percival, Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L, J. Med. Chem. 44 (2001) 94-104","DOI":"10.1021\/jm0003440"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0105.2","doi-asserted-by":"crossref","unstructured":"(b) R. L\u00f6ser, M. Frizler, K. Schilling, M. G\u00fctschow, Azadipeptide Nitriles: Highly Potent and Proteolytically Stable Inhibitors of Papain-Like Cysteine Proteases, Angew. Chem. Int. Ed. 47 (2008) 4331-4334","DOI":"10.1002\/anie.200705858"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0105.3","doi-asserted-by":"crossref","unstructured":"(c) P.Y. Yang, M.Wang, L. Li, H. Wu, C.Y. He, S.Q. Yao, Design, Synthesis and Biological Evaluation of Potent Azadipeptide Nitrile Inhibitors and Activity-based Probes as Promising Anti-Trypanosoma brucei Agents, Chem. Eur. J. 18 (2012) 6528-6541","DOI":"10.1002\/chem.201103322"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0105.4","doi-asserted-by":"crossref","unstructured":"(d) A. Casimiro-Garcia, J.I. Trujillo, F. Vajdos, B. Juba, M.E. Banker, A. Aulabaugh, P. Balbo, J. Bauman, J. Chrencik, J.W. Coe, R. Czerwinski, M. Dowty, J.D. Knafels, S. Kwon, L. Leung, S. Liang, R.P. Robinson, J.B. Telliez, R. Unwalla, X. Yang, A. Thorarensen, Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors, J. Med. Chem. 61 (2018) 10665-10699","DOI":"10.1021\/acs.jmedchem.8b01308"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0105.5","doi-asserted-by":"crossref","unstructured":"(e) J. Breidenbach, C. Lemke, T. Pillaiyar, L. Sch\u00e4kel, G. Al Hamwi, M. Diett, R. Gedschold, N. Geiger, V. Lopez, S. Mirza, V. Namasivayam, A.C. Schiedel, K. Sylvester, D. Thimm, C. Vielmuth, L.P. Vu, M. Zyulina, J. Bodem, M. G\u00fctschow, C.E. M\u00fcller, Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors, Angew. Chem. Int. Ed. 60 (2021) 10423-10429","DOI":"10.1002\/anie.202016961"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0105.6","doi-asserted-by":"crossref","unstructured":"(f) K. Bum-Erdene, I.J. Yeh, G. Gonzalez-Gutierrez, M.K. Ghozayel, K. Pollok, S.O. Meroueh, Small-Molecule Cyanamide Pan-TEAD\u00b7YAP1 Covalent Antagonists, J. Med. Chem. 66 (2023) 266-284.","DOI":"10.1021\/acs.jmedchem.2c01189"},{"key":"10.1016\/j.bioorg.2023.106725_b0110","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/14756366.2022.2138367","article-title":"4-Cyanamidobenzenesulfonamide Derivatives: a Novel Class of Human and Bacterial Carbonic Anhydrase Inhibitors","volume":"38","author":"Abdoli","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0115.1","doi-asserted-by":"crossref","unstructured":"For recent example, see (a) M. Abdoli, A. Bonardi, C.T. Supuran, R. \u017dalubovskis, Investigation of Novel Alkyl\/benzyl (4-sulphamoylphenyl) carbamimidothioates as Carbonic Anhydrase Inhibitors, J. Enzyme Inhib. Med. Chem. 38 (2023) 2152811","DOI":"10.1080\/14756366.2022.2152811"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0115.2","doi-asserted-by":"crossref","unstructured":"(b) J. Ivanova, M. Abdoli, A. Nocentini, R. \u017dalubovskis, C.T. Supuran, Derivatives of 4-Methyl-1,2,3-benzoxathiazine 2,2-dioxide as Selective Inhibitors of Human Carbonic Anhydrases IX and XII over the Cytosolic Isoforms I and II, J. Enzyme Inhib. Med. Chem. 38 (2023) 2170370","DOI":"10.1080\/14756366.2023.2170370"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0115.3","doi-asserted-by":"crossref","unstructured":"(c) M. Abdoli, C.T. Supuran, R. \u017dalubovskis, 2-((1H-Benzo[d]imidazol-2-yl)amino)benzo[d]thiazole-6-sulphonamides: A Class of Carbonic Anhydrase II and VII-selective Inhibitors, J Enzyme Inhib. Med. Chem. 38 (2023) 2174981.","DOI":"10.1080\/14756366.2023.2174981"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0120.1","doi-asserted-by":"crossref","unstructured":"For recent examples, see (a) C. Lemke, A. J\u00edlkov\u00e1, D. Ferber, A. Braune, A. On, P. Johe, A. Z\u00edkov\u00e1, T. Schirmeister, M. Mare\u0161, M. Horn, M. G\u00fctschow, Two Tags in One Probe: Combining Fluorescence- and Biotin-based Detection of the Trypanosomal Cysteine Protease Rhodesain, Chem. Eur. J. 28 (2022) e202201636","DOI":"10.1002\/chem.202201636"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0120.2","doi-asserted-by":"crossref","unstructured":"(b) J. Ben\u00fd\u0161ek, M. Bu\u0161a, P. Rube\u0161ov\u00e1, J. Fanfrl\u00edk, M. Lep\u0161\u00edk, J. Brynda, Z. Matou\u0161kov\u00e1, U. Bartz, M. Horn, M. G\u00fctschow, M. Mare\u0161, Highly Potent Inhibitors of Cathepsin K with a Differently Positioned Cyanohydrazide Warhead: Structural Analysis of Binding Mode to Mature and Zymogen-like Enzymes, J. Enzyme Inhib. Med. Chem. 37 (2022) 515-526.","DOI":"10.1080\/14756366.2021.2024527"},{"key":"10.1016\/j.bioorg.2023.106725_b0125","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1039\/C8OB01770K","article-title":"Recent Developments and Applications of Cyanamides in Electrophilic Cyanation","volume":"16","author":"Chaitanya","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2023.106725_b0130","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/asia.200700372","article-title":"Synthesis and Structure of Monomeric, Trimeric, and Mixed phenylcyanamides","volume":"3","author":"Brand","year":"2008","journal-title":"Chem. Asian J."},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0135.1","doi-asserted-by":"crossref","unstructured":"(a) S. Durdagi, D. Vullo, P. Pan, N. K\u00e4hk\u00f6nen, J.A. M\u00e4\u00e4tt\u00e4, V.P. Hyt\u00f6nen, A. Scozzafava, S. Parkkila, C.T. Supuran, Protein-protein Interactions: Inhibition of Mammalian Carbonic Anhydrases I-XV by the Murine Inhibitor of Carbonic Anhydrase and Other Members of the Transferrin Family, J. Med. Chem. 55 (2012) 5529-5535","DOI":"10.1021\/jm3004587"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0135.2","doi-asserted-by":"crossref","unstructured":"(b) Aspatwar, M.E. Tolvanen, H. Barker, L. Syrj\u00e4nen, S. Valanne, S. Purmonen, A. Waheed, W.S. Sly, S. Parkkila, Carbonic Anhydrases in Metazoan Model Organisms: Molecules, Mechanisms, and Physiology, Physiol. Rev. 102 (2022) 1327-1383.","DOI":"10.1152\/physrev.00018.2021"},{"key":"10.1016\/j.bioorg.2023.106725_b0140","doi-asserted-by":"crossref","unstructured":"S. Yogosawa, J. Nakayama, M. Nishi, A. Ryo, K. Yoshida, Carbonic Anhydrase 13 Suppresses Bone Metastasis in Breast Cancer, Cancer Treat. Res. Commun. 27 (2021) 100332.","DOI":"10.1016\/j.ctarc.2021.100332"},{"key":"10.1016\/j.bioorg.2023.106725_b0145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/metabo11040225","article-title":"Synthesis and Biological Evaluation of Coumarin-Linked 4-Anilinomethyl-1,2,3-Triazoles as Potent Inhibitors of Carbonic Anhydrases IX and XIII Involved in Tumorigenesis","volume":"11","author":"Thacker","year":"2021","journal-title":"Metabolites."},{"key":"10.1016\/j.bioorg.2023.106725_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bmc.2018.10.017","article-title":"Cathepsin B: Active Site Mapping with Peptidic Substrates and Inhibitors","volume":"27","author":"Schmitz","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106725_b0155","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canlet.2019.02.035","article-title":"Cathepsin B: A Sellsword of Cancer Progression","volume":"449","author":"Mijanovi\u0107","year":"2019","journal-title":"Cancer Lett."},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0160.1","doi-asserted-by":"crossref","unstructured":"(a) U. Neumann, M. G\u00fctschow, 3,1-Benzothiazin-4-ones and 3,1-Benzoxazin-4-ones: Highly Different Activities in Chymotrypsin Inactivation, Bioorg. Chem. 23 (1995) 72-88","DOI":"10.1006\/bioo.1995.1006"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0160.2","doi-asserted-by":"crossref","unstructured":"(b) J. Singh, R.C. Petter, T.A. Baillie, A. Whitty, The Resurgence of Covalent Drugs, Nat. Rev. Drug Discov. 10 (2011) 307-317","DOI":"10.1038\/nrd3410"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0160.3","doi-asserted-by":"crossref","unstructured":"(c) D. Schaefer, X. Cheng, Recent Advances in Covalent Drug Discovery, Pharmaceuticals. 16 (2023) 663.","DOI":"10.3390\/ph16050663"},{"key":"10.1016\/j.bioorg.2023.106725_b0165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13000-023-01325-9","article-title":"The Relationship between Carbonic Anhydrase IX (CAIX) and Patient Survival in Breast Cancer: Systematic Review and Meta-Analysis","volume":"18","author":"Shamis","year":"2023","journal-title":"Diagn. Pathol."},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0170.1","doi-asserted-by":"crossref","unstructured":"(a) R.G. Khalifah, The Carbon Dioxide Hydration Activity of Carbonic Anhydrase: I. Stop-flow Kinetic Studies on the Native Human Isoenzymes B and C, J. Biol. Chem. 246 (1971) 2561-2573","DOI":"10.1016\/S0021-9258(18)62326-9"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0170.2","doi-asserted-by":"crossref","unstructured":"(b) H. Carreyre, J.M. Coustard, G. Carr\u00e9, C. Vandebrouck, J. Bescond, M. Ou\u00e9draogo, J. Marrot, D. Vullo, C.T. Supuran, S. Thibaudeau, Natural Product Hybrid and its Superacid Synthesized Analogues: Dodoneine and its Derivatives Show Selective Inhibition of Carbonic Anhydrase Isoforms I, III, XIII and XIV, Bioorg. Med. Chem. 21 (2013) 3790-3794.","DOI":"10.1016\/j.bmc.2013.04.041"},{"key":"10.1016\/j.bioorg.2023.106725_b9000","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.enzmictec.2017.06.002","article-title":"Preparation and Characterization of Carbonic Anhydrase-conjugated Liposomes for Catalytic Synthesis of Calcium Carbonate Particles","volume":"105","author":"Maeshima","year":"2017","journal-title":"Enzyme Microb. Technol."},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0175.1","doi-asserted-by":"crossref","unstructured":"(a) A. Y\u0131ld\u0131r\u0131m, U. Atmaca, A. Keskin, M. Topal, M. Celik, \u0130. G\u00fcl\u00e7in, C. T. Supuran, N-Acylsulfonamides Strongly Inhibit Human Carbonic Anhydrase Isoenzymes I and II, Bioorg. Med. Chem. 23 (2015) 2598-2605","DOI":"10.1016\/j.bmc.2014.12.054"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.106725_b0175.2","doi-asserted-by":"crossref","unstructured":"(b) A. Innocenti, \u0130. G\u00fcl\u00e7in, A. Scozzafava, C. T. Supuran, Carbonic Anhydrase Inhibitors. Antioxidant Polyphenols Effectively Inhibit Mammalian Isoforms I-XV, Bioorg. Med. Chem. Lett. 20 (2010) 5050-5053.","DOI":"10.1016\/j.bmcl.2010.07.038"},{"key":"10.1016\/j.bioorg.2023.106725_b0180","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/cbic.201300806","article-title":"A Coumarin-labeled Vinyl Sulfone as Tripeptidomimetic Activity-based Probe for Cysteine Cathepsins","volume":"15","author":"Mertens","year":"2014","journal-title":"ChemBioChem."},{"key":"10.1016\/j.bioorg.2023.106725_b0185","doi-asserted-by":"crossref","first-page":"11419","DOI":"10.1002\/chem.201101350","article-title":"Facing the gem-Dialkyl Effect in Enzyme Inhibitor Design: Preparation of Homocycloleucine-Based Azadipeptide Nitriles","volume":"17","author":"Frizler","year":"2011","journal-title":"Chem. Eur. J."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823003863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823003863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:50:00Z","timestamp":1758617400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823003863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":70,"alternative-id":["S0045206823003863"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106725","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4-Cyanamido-substituted benzenesulfonamides act as dual carbonic anhydrase and cathepsin inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106725"}}